Premium
Pharmacokinetics of Sirolimus in Stable Renal Transplant Patients after Multiple Oral Dose Administration
Author(s) -
Zimmerman James J.,
Kahan Barry D.
Publication year - 1997
Publication title -
the journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.92
H-Index - 116
eISSN - 1552-4604
pISSN - 0091-2700
DOI - 10.1002/j.1552-4604.1997.tb04318.x
Subject(s) - pharmacokinetics , sirolimus , urology , medicine , volume of distribution , trough concentration , trough level , oral administration , area under the curve , steady state (chemistry) , pharmacology , chemistry , transplantation , tacrolimus
In this 2‐week, ascending dose study, the pharmacokinetic activity of sirolimus was examined in 40 stable renal transplant patients treated with cyclosporine and prednisone. Nine dose levels (range, 0.5–6.5 mg/m 2 /12 hr) of sirolimus were studied in a parallel design. Mean values for the pharmacokinetic parameters of sirolimus calculated in all dose groups were as follows: time to peak blood concentration, 1.4 ± 1.2 hours; terminal half‐life, 62 ± 16 hours; oral dose clearance, 208 ± 95 mL/h/kg; apparent oral steady‐state volume of distribution, 12 ± 5 L/kg; and blood/plasma ratio, 38 ± 13. The intersubject variabilities in dose clearance, steady‐state volume of distribution, and blood/plasma ratio were 4.5‐fold. Preliminary assessments suggested linear dose proportionality. An excellent correlation existed between area under the concentration—time curve and trough blood concentration at steady state. Sirolimus did not produce any significant changes in area under the concentration—time curve of cyclosporine. Preliminary analysis suggested that values for the pharmacokinetic parameters of sirolimus vary among races (black versus nonblack) but not among genders.